- Moneycontrol /
- Market /
- Pharmaceuticals /
- YEARLY RESULTS
BSE Live
Jan 20, 16:00Prev. Close
1.99
Open Price
1.99
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Yearly Results of Raymed Labs (in Rs. Cr.) | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 | |
| Net Sales/Income from operations | -- | -- | -- | -- | -- | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | -- | -- | -- | -- | -- | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | -- | -- | -- | -- | -- | |
| Purchase of Traded Goods | -- | -- | -- | -- | -- | |
| Increase/Decrease in Stocks | -- | -- | -- | -- | -- | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | -- | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.04 | -0.04 | -0.04 | -0.03 | -0.04 | |
| Other Income | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
| P/L Before Int., Excpt. Items & Tax | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 | |
| Interest | -- | -- | -- | -- | -- | |
| P/L Before Exceptional Items & Tax | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 | |
| Exceptional Items | -0.03 | -0.03 | -0.02 | -0.02 | -- | |
| P/L Before Tax | -0.05 | -0.06 | -0.05 | -0.04 | -0.02 | |
| Tax | -- | -- | -- | -- | -- | |
| P/L After Tax from Ordinary Activities | -0.05 | -0.06 | -0.05 | -0.04 | -0.02 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | -0.05 | -0.06 | -0.05 | -0.04 | -0.02 | |
| Equity Share Capital | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | |
| Reserves Excluding Revaluation Reserves | -6.20 | -6.15 | -6.09 | -6.04 | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | -0.12 | -0.13 | -0.11 | -0.01 | -0.04 | |
| Diluted EPS | -0.12 | -0.13 | -0.11 | -0.01 | -0.04 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | -0.12 | -0.13 | -0.11 | -0.01 | -0.04 | |
| Diluted EPS. | -0.12 | -0.13 | -0.11 | -0.01 | -0.04 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | 0.31 | 0.31 | |
| Share Holding (%) | -- | -- | -- | 71.64 | 71.64 | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | 0.12 | 0.12 | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | 100.00 | 100.00 | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | 28.36 | 28.36 |
